|
THE 3rd INTERNATIONAL EOSINOPHIL SYMPOSIUM: “EOSINOPHIL RISING 2003”
Steven Ackerman1, Redwan Moqbel2 and Judah Denburg3
1Department of Biochemistry and Molecular Genetics, University of Illinois, Chicago, IL USA, 2Department of Medicine, University of Alberta, Edmonton, AB, Canada, 3Department of Medicine, Division of Clinical Immunology and Allergy, McMaster University, Hamilton, ON, Canada
Background: The 3rd Biennial International Eosinophil Symposium scheduled for June 25-29, 2003 at the Snowmass Conference Center, Snowmass Village Resort at Aspen, CO. The Symposium is being held
under the auspices of the International Eosinophil Society.
Objectives: The meeting will consist of invited talks by leaders in eosinophil research and allied fields from the perspectives of asthma, allergy, gastrointestinal, hematologic, neoplastic, fibrotic,
and tropical/parasitic diseases. The focus will be on basic aspects of eosinophil cellular, molecular and immunobiology, and clinical issues relevant to the functions of eosinophils in both normal physiology,
inflammation and disease pathogenesis. The symposium will cover the following major themes: (1) Eosinophil growth, differentiation, gene transcription, expression and regulation, survival, death;
(2) Eosinophil receptors, signaling, priming, adhesion, activation and mediator secretion; (3) Eosinophils among inflammatory and stromal cells – functional interactions and contrasts;
(4) Animal models of eosinophil roles and functions in asthma, allergy, parasitic and gastrointestinal diseases, and viral infections; (5) Clinical aspects and issues in eosinophil function in asthma,
allergy, other eosinophil-associated diseases, tissue pathology, remodeling and fibrosis; (6) New therapeutics, basic and clinical research strategies, and future directions
Methodology:
The meeting will host ~35 invited featured speakers, and 24 additional oral talks (10 min + 5 min discussion) and ~50 posters which will be selected from submitted abstracts of junior scientists (graduate students, postdoctoral fellows, junior faculty). More than 200 participants are anticipated who will have the opportunity to submit abstracts for selection for oral or poster presentations. A cutting edge program of basic, translational, and clinical research is being prepared by members of the Organizing Committee and its International Scientific Advisory Board.
Results: The symposium will accomplish the following goals: (1) Provide a venue for bringing together basic and clinical scientists addressing eosinophil biology at different organizational levels and in
animal models to foster understanding of their roles in normal versus pathophysiologic conditions, (2) Bring together basic and clinical investigators to foster the development of clinical therapeutics, diagnostic
tests and other treatments of eosinophil-associated diseases based on understanding eosinophil immunobiology and inflammatory functions, (3) Provide participants with the latest information on eosinophil basic and
clincial research by including many short talks from submitted abstracts, (4) Provide all participants with opportunities for in-depth discussions and exchange of ideas with speakers and poster presenters for
cross-fertilization and establishment of collaborations between basic and clinical disciplines, and (5) Provide an interactive forum for effective scientific exchange amongst senior and promising junior scientists
and minorities working in the fields of allergy, immunology, tropical diseases, hematology, and cancer research in terms of the functions of eosinophils in normal physiology in health and pathophysiology in disease.
Conclusions: We anticipate an outstanding cutting edge scientific program of basic, translational and clinical research on the eosinophil in normal physiology and disease pathogenesis.
Funded by the National Institutes of Health, and the pharmaceutical and biotechnology industries
[Top]
|
